Financial Gravity Asset Management’s Twist Bioscience TWST Stock Holding History

Financial Gravity Asset Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7	Closed	-$283	–	2373
2024 Q1	$283	Buy	7 +3	+75%	+$108	﹤0.01%	1545
2023 Q4	$106	Buy	4 +2	+100%	+$46	﹤0.01%	1257
2023 Q3	$31	Sell	2 -18	-90%	-$396	﹤0.01%	1095
2023 Q2	$127	Buy	20 +5	+33%	+$75	﹤0.01%	1267
2023 Q1	$5	Sell	15 -9	-38%	-$199	﹤0.01%	925
2022 Q4	$39	Sell	24 -81	-77%	-$2.35K	﹤0.01%	1250
2022 Q3	$13	Hold	105	–	–	﹤0.01%	747
2022 Q2	$13	Sell	105 -42	-29%	-$1.49K	﹤0.01%	664
2022 Q1	$17	Sell	147 -84	-36%	-$4.66K	﹤0.01%	729
2021 Q4	$26	Buy	+231	New	+$23.7K	﹤0.01%	801
2021 Q3	–	Hold	0	–	–	–	340

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Financial Gravity Asset Management's TWST Position: Q2 2024 in Review

Financial Gravity Asset Management sold out of Twist Bioscience (TWST) in Q2 2024, closing a stake of 7 shares — an estimated $283 sold.

Financial Gravity Asset Management first reported a position in TWST in Q4 2021 and held it in 10 quarters. The position peaked at $283 in Q1 2024. 262 funds tracked by Wall St. Rank hold TWST as of Q2 2024.

Financial Gravity Asset Management reported no remaining Twist Bioscience position as of Q2 2024 after selling out during the quarter.
Financial Gravity Asset Management sold 7 Twist Bioscience shares in Q2 2024, an estimated $283.
Financial Gravity Asset Management first reported a position in Twist Bioscience in Q4 2021 and held it in 10 quarters.
Financial Gravity Asset Management's Twist Bioscience position peaked at $283 in Q1 2024.
262 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2024.

Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.